Orchestra BioMed (OBIO) CFO has 3,076 RSU shares withheld for taxes

Rhea-AI Filing Summary

Orchestra BioMed Holdings, Inc. Chief Financial Officer Andrew Taylor Lawrence had 3,076 shares of common stock withheld at a price of $3.98 per share to cover tax obligations tied to vesting restricted stock units. No shares were sold in the market, and he now holds 629,417 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Taylor Andrew Lawrence

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock, par value $0.0001 per share	3,076	$3.98	$12K

Holdings After Transaction: Common Stock, par value $0.0001 per share — 629,417 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 3,076 shares Withholding price per share: $3.98 per share Shares held after transaction: 629,417 shares

3 metrics

Shares withheld for taxes 3,076 shares Tax-withholding disposition on RSU vesting

Withholding price per share $3.98 per share Value used for RSU tax withholding

Shares held after transaction 629,417 shares CFO’s direct ownership following tax withholding

Key Terms

restricted stock units ("RSUs"), tax withholding obligations, withholding of shares, Common Stock, par value $0.0001 per share

4 terms

restricted stock units ("RSUs") financial

"in connection with vesting of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

tax withholding obligations financial

"to satisfy tax withholding obligations in connection with vesting of restricted stock units"

withholding of shares financial

"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations"

Common Stock, par value $0.0001 per share financial

"security_title": "Common Stock, par value $0.0001 per share""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Andrew Lawrence

(Last) (First) (Middle)

C/O ORCHESTRA BIOMED HOLDINGS, INC.

150 UNION SQUARE DRIVE

(Street)

NEW HOPE PENNSYLVANIA 18938

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orchestra BioMed Holdings, Inc. [ OBIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	05/28/2026		F(1)		3,076	D	$3.98	629,417	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

	/s/ Andrew Taylor	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Orchestra BioMed (OBIO) report for its CFO?

Orchestra BioMed’s CFO had shares withheld for taxes, not sold. On vesting of RSUs, 3,076 common shares were withheld at $3.98 each to satisfy tax obligations, with no open-market sale involved.

How many Orchestra BioMed (OBIO) shares were withheld for the CFO’s tax obligations?

A total of 3,076 shares were withheld for tax obligations. These common shares, valued at $3.98 per share, covered taxes due upon vesting of restricted stock units rather than being sold in the open market.

Did the Orchestra BioMed (OBIO) CFO sell any shares in the market?

No, the CFO did not sell shares in the market. The 3,076 shares reported were withheld by the company to satisfy tax withholding obligations tied to RSU vesting, with no market transactions executed.

How many Orchestra BioMed (OBIO) shares does the CFO hold after this transaction?

The CFO holds 629,417 common shares after the transaction. This figure reflects his direct ownership following the tax-withholding disposition related to vested restricted stock units, as reported in the filing.

What does a tax-withholding disposition mean in the Orchestra BioMed (OBIO) Form 4?

It means shares were retained by the issuer to pay taxes. Instead of selling stock in the market, 3,076 vested RSU shares were withheld by Orchestra BioMed to cover the CFO’s associated tax liabilities.